A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of Intracerebral Injection of LY-N001 Injection for the Treatment of Moderate to Advanced Parkinson's Disease With GBA1 Mutations
Clinical trial NCT07685444 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07685444
- Sponsor
- Lingyi Biotech Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-07
- Primary completion
- 2028-07-07
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.